
--- Page 1 ---
UUID:A845013D-BF15-42FB-8BFE-FCE206E943FE Redacted TCGA-C8-A12N-01A-PR IrB ApPROVED Form 1 Cunical Case Report (For Collection of Cancerous Tissue).. ic4-0-3 IPAA Cauinonn, nifil+nHng duct,NOs 8560|3 St: bresst,nos c5o.9 Informed Consent Aw 5|31| I personally informed this patient that a specimen(s) would be collected to be used for research RESEARCH SUBJECT INFORMATION AND CONSENT purposes. I reviewed the FORM with the patient and answered any questions the patient had. The patient then signed the consent form as a free and voluntary act. A copy of this informed consent document will be retained at our institution. Date Signature Name of Physician or Study Coordinator Clinical Information Race  Temperature Height Mari*-1 c+-tus Date of Birth (mm/dd/yyyy) Heart Rate  Blood Pressure Gendar Weight Chief Complaints: 1numr iy te Riqht beayT Symptoms: Daheut fTmol xtr i, Ha teqGF beaytp meyenr.N ;Heersymy Clinical Findings: Wien Performance Scale (Karnofsky Score):   60-70 Symptomatic, in bed less than 50% of day   100 Asymptomatic  80-90 Symptomatic but Fully Ambulatory  20-30 Bed Ridden  40-50 Symptomatic, in bed more than 50% of day, but not bed ridden Date (mm/dd/yyyy) Route Frequency Dose Drug To To NO To To To

--- Page 2 ---
 PASTMEDICAL HISTORY Status Treatment Diagnosis Date Diagnosis/Disease/Disorder/Injury POBGYN.HISTORYAPY # of Pregnancies Date of First Menses  Menopausal Status   Pre-menopausal # of Live Births Date of Last Menses  Peri-Menopausal Post-menopausal  Hormone Replacement Birth Control: Therapy: W SOCIALHISTORYKAA Environmental Hazards: Occupation: Smoking History. When Quit  Packs/day Duration TYPE (yr) Current Status (yrs)  yes NO Alcohol Consumption Duration When Quit  Drinks/day TYPE (yr) Current Status (yrs)  yES no Drug Use Duration When Quit Frequency TYPE (yr Current Status (yrs)  yes NO Age of Diagnosis  Diagnosis  Relative Yas Cas eex. Date CCSCMEABDATAS  Result Date Test  Result  Negative  Positive: Test CEA Negative  Positive: _ Negative  Positive: HIV CA 15-3  Positive: Negative   Negative  Positive: Hep B  CA 19-9  Positive:   Negative  Positive: Hep C   Negative PSA  Positive: AFP   Negative Other:  Negative  Positive: Other:  Negative  Positive: B/T Cell Markers: 2

--- Page 3 ---
FDIAGNOSTICSTUDIES Date  Results Study Ultrasound X-Ray CT Endoscopy MRI Biopsy Preoperative Clinical Diagnosis Reght neu,!Caue Location of Suspected Distant Metastasis. Location of Suspected Involved Lymph Nodes. Axill Date of Diagnosis Clinical Staging Nj Mo Stage: Treatment Information BTAARSCSURGICAETREATMENEAOAASRNA Date of Procedure Procedure Suraern 'Primary Tumor Size  Detailed Location Organ x x cm bype-wne quadra Keerst Extension of Tumor N0 Lymph Nodes # of Lymph Nodes Location of Lymph Nodes Description S Axilla Palpable, Non-Dissected Lymph Nodes Dissected Lymph Nodes Distant Metastasis Size Detailed Location  Organ NO Surgical Staging Stage: 7A No. Mo T9 aNEOADJUVENTTHERAPY(Chemo Radiaton Immuno, Hormonal orMolecular Date (mm/dd/yyyy) Route Frequency Dose 1 To Drug/Treatment 1 To 1 To To / 1 To 1 3

--- Page 4 ---
Pathology Form Specimen Information Date. Time: Collected by: Date: Fime: Preserved by: w.SPECIMENTYPE(#Ofsamples provided)S Slide Blood/Serum/Plasma  Paraffin Block Diseased Normal Frozen Normal Diseased  Norma! Normal Diseased Diseased x X x Time to LN2 Time to Formalin Time to LN2 min  min 40 min  EKTL PATHOLOGICAIEDESCRIPTION Primary Tumor Distance to NAT Size Extension of Tumor Organ NO cm I x Bseces X cm Lymph Nodes # Metastasized # Examined  Location 0 Axilla Distant Metastasis Size Detailed Locatlon Organ NO Pathological Staging TA. Mo Stage: No pT 9  Notes: 4

--- Page 5 ---
Microscopic Description + Structural Pattern + Cell Distribution +  Streaming Diffuse  Storiform Mosaic Fibrosis Necrosis Palisading Lymphocytic Infiltration Cystic Degeneration Vascular Invasion  Bleeding Clusterized  Myxoid Change  Alveolar Formation Psammoma/Calcification  Indian File Lymphomatous wwwaCellularDifferentiationowwwww Sarcomatous + Adenomatous + Large Cell  Squamous  Round Cell Glandular cell + Small Cell  Squamoid Cell Fibroblast  Cell Stratification  RS Cell/RS Like Spindle Cell Osteoblast  Secretion Inflam. Cell Keratin Lipoblast Intracyt. Vacuole Plasma Cell Desmosome Myoblast  Gland formation  Poor Well X Moderate  Pearl Ceilular Differentiation: II III 0 I Nuclear Atypia: + Aniso Nucleosis + Hyperchromatism Nucleolar Prominent Multinucleated Giant Cell + Mitotic Activity Nuclear Grade: Date Value  Result  Marker  Negative  Positive ER  Negative  Positive PR Negative   Positive  Her-2/neu  Negative  Positive B-Cell Marker  Positive  Negative  T-Cell Marker  Negative  Positive Other: Negative  Positive Other: Final Pathology Report luciaf Criuma Lmaswe Grade: Histological Diagnosis: Comments: Date  Pathologist Principal Investigator U

--- Page 6 ---
COnsOlIdated Diagnostic patholOgy fOrm* Microscopic Appearance: Histological pattern: J. CELL DISTRIBUTION Diffuse + STRUCTURALPATTERN Streaming Mosaic  Storiform Necrosis Fibrosis Lymphocytic Infiltration Palisading Vascular Invasion Cystic Degeneration Clusterized X Bleeding Alveolar Formation YMyxoid Change Indian File Psammoma/Calcification 2. Cellular features: Squamous [+-Adenomatous + Sarcomatous Lymphomatous + Squamoid Cell Glandular cell  Round Cell Large Cell Spindle Cell Cell Stratification 9 Fibroblast Small Cell Keratin Secretion Osteoblast RS CeI/RS Like  Desmosome Intracyt. Vacuole  Lipoblast Inflam. Cell Pear! Gland formation  Myoblast Plasma Cell Otherwise Specified: D, 307 Dr 70% 2.Cellular Differentiation: Well Moderately Poor Nuclear Atypia: Nuclear Appearance Aniso Nucleosis Hyperchromatism Nucleolar Prominent Multinucleated Giant Cell Mitotic Activity Nuclear Grade Comments: A Date Director, Research Pathology PATHOLOGIST STAFF FOR RESEARCH USE ONLY). *(INTEGRATED REPORT OF FINDINGS BY CONTRIBUTOR AND